Exogenous and Endogenous Hormones in Relation to Glioma in Women: A Meta-analysis of 11 Case-Control Studies

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Qi, Zhen Yu ^a   Shao, Chuan ^a   Zhang, Xin ^a   Hui, Guo Zhen ^a   Wang, Zhong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT; SEX HORMONE;

ARTICLE; BIRTH; CANCER RISK; CONTROLLED STUDY; FEMALE; GLIOMA; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; META ANALYSIS; ONSET AGE; PARITY; POPULATION BASED CASE CONTROL STUDY; REPRODUCTION; RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 84880737816     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068695     Document Type: Article

References (43)

1. Ohgaki H, Kleihues P, (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109: 93-108.
2. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M, (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2: 494-503.
3. Lönn S, Klaeboe L, Hall P, Mathiesen T, Auvinen A, et al. (2004) Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer 108: 450-5.
4. McKinley BP, Michalek AM, Fenstermaker RA, Plunkett RJ, (2000) The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J Neurosurg 93: 932-9.
5. Cowppli-Bony A, Bouvier G, Rué M, Loiseau H, Vital A, et al. (2011) Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control 22: 697-714.
6. Whittle IR, Hawkins RA, Miller JD, (1987) Sex hormone receptors in intracranial tumours and normal brain. Eur J Surg Oncol 13: 303-7.
7. Carroll RS, Zhang J, Dashner K, Sar M, Black PM, (1995) Steroid hormone receptors in astrocytic neoplasms. Neurosurgery 37: 496-503.
8. Khalid MH, Shibata S, Furukawa K, Nadel A, Ammerman MD, et al. (2004) Role of estrogen receptor-related antigen in initiating the growth of human glioma cells. J Neurosurg 100: 923-30.
9. Chamaon K, Stojek J, Kanakis D, Braeuninger S, Kirches E, et al. (2005) Micromolar concentrations of 2-methoxyestradiol kill glioma cells by an apoptotic mechanism, without destroying their microtubule cytoskeleton. J Neurooncol 72: 11-6.
10. Lis A, Ciesielski MJ, Barone TA, Scott BE, Fenstermaker RA, et al. (2004) 2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro. Cancer Lett 213: 57-65.
11. Verzat C, Delisle MB, Courriere P, Hollande E, (1990) Influence of host sex on the growth of a human glioblastoma line in athymic mice. Neuropathol Appl Neurobiol 16: 141-51.
12. Plunkett RJ, Lis A, Barone TA, Fronckowiak MD, Greenberg SJ, (1999) Hormonal effects on glioblastoma multiforme in the nude rat model. J Neurosurg 90: 1072-7.
13. Barone TA, Gorski JW, Greenberg SJ, Plunkett RJ, (2009) Estrogen increases survival in an orthotopic model of glioblastoma. J Neurooncol 95: 37-48.
14. Sterne J. (2009) Meta-analysis in Stata: an updated collection from the Stata Journal. Stata Press.
15. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-58.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-60.
17. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-88.
18. Gandini S, Iodice S, Koomen E, Di Pietro A, Sera F, et al. (2011) Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. Eur J Cancer 47: 2607-17.
19. Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, et al. (2012) Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 21: 20-38.
20. Wigertz A, Lönn S, Mathiesen T, Ahlbom A, Hall P, et al. (2006) Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 164: 629-36.
21. Huang K, Whelan EA, Ruder AM, Ward EM, Deddens JA, et al. (2004) Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev 13: 1583-8.
22. Felini MJ, Olshan AF, Schroeder JC, Carozza SE, Miike R, et al. (2009) Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control 20: 87-96.
23. Wang SS, Hartge P, Yeager M, Carreón T, Ruder AM, et al. (2011) Joint associations between genetic variants and reproductive factors in glioma risk among women. Am J Epidemiol 174: 901-8.
24. Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, et al. (2005) Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 114: 797-805.
25. Cantor KP, Lynch CF, Johnson D, (1993) Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 4: 505-11.
26. Lambe M, Coogan P, Baron J, (1997) Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer 72: 389-93.
27. Wigertz A, Lönn S, Hall P, Auvinen A, Christensen HC, et al. (2008) Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 17: 2663-70.
28. Schlehofer B, Blettner M, Wahrendorf J, (1992) Association between brain tumors and menopausal status. J Natl Cancer Inst 84: 1346-9.
29. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, et al. (1999) Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82: 155-60.
30. Ryan P, Lee MW, North B, McMichael AJ, (1992) Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 51: 20-7.
31. Plesko I, Preston-Martin S, Day NE, Tzonou A, Dimitrova E, et al. (1985) Parity and cancer risk in Slovakia. Int J Cancer 36: 529-33.
32. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L, (1989) Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 44: 833-9.
33. Persson I, Yuen J, Bergkvist L, Schairer C, (1996) Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy-long-term follow-up of a Swedish cohort. Int J Cancer 67: 327-32.
34. Miller AB, Barclay TH, Choi NW, Grace MG, Wall C, et al. (1980) A study of cancer, parity and age at first pregnancy. J Chronic Dis 33: 595-605.
35. Chiu HF, Chen CC, Tsai SS, Ho SC, Yang CY, (2012) Parity, age at first birth, and risk of death from brain cancer: a population-based cohort study in Taiwan. BMC Public Health 12: 857.
36. Silvera SA, Miller AB, Rohan TE, (2006) Hormonal and reproductive factors and risk of glioma: a prospective cohort study. Int J Cancer 118: 1321-4.
37. Benson VS, Pirie K, Green J, Casabonne D, Beral V, et al. (2008) Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer 99: 185-90.
38. Benson VS, Pirie K, Green J, Bull D, Casabonne D, et al. (2010) Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study. Int J Cancer 127: 1692-8.
39. Kabat GC, Park Y, Hollenbeck AR, Schatzkin A, Rohan TE, (2011) Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study. Int J Cancer 128: 944-50.
40. Michaud DS, Gallo V, Schlehofer B, Tjønneland A, Olsen A, et al. (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19: 2562-9.
41. Hochberg F, Toniolo P, Cole P, Salcman M, (1990) Nonoccupational risk indicators of glioblastoma in adults. J Neurooncol 8: 55-60.
42. Cicuttini FM, Hurley SF, Forbes A, Donnan GA, Salzberg M, et al. (1997) Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer 71: 203-7.
43. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321-33.